ARTICLE | Company News
AviGenics, Geron, Origen Therapeutics Inc. deal
January 2, 2001 8:00 AM UTC
AviGenics and Origen received options for non-exclusive worldwide licenses to GERN's nuclear transfer technology for avian applications (developing cloned poultry). The companies will use the GERN tec...